ROBERT M SHANKS

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. ncbi Development of a novel system for isolating genes involved in predator-prey interactions using host independent derivatives of Bdellovibrio bacteriovorus 109J
    Adrian A Medina
    Department of Oral Biology, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07101, USA
    BMC Microbiol 8:33. 2008
  2. ncbi Global transcriptional response to mammalian temperature provides new insight into Francisella tularensis pathogenesis
    Joseph Horzempa
    Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
    BMC Microbiol 8:172. 2008
  3. ncbi New yeast recombineering tools for bacteria
    Robert M Q Shanks
    Department of Ophthalmology, University of Pittsburgh Eye Center, PA 15213, USA
    Plasmid 62:88-97. 2009
  4. ncbi A Serratia marcescens OxyR homolog mediates surface attachment and biofilm formation
    Robert M Q Shanks
    Charles T Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, UPMC Eye Center, Pittsburgh, PA 15213, USA
    J Bacteriol 189:7262-72. 2007
  5. ncbi The cyclic AMP-dependent catabolite repression system of Serratia marcescens mediates biofilm formation through regulation of type 1 fimbriae
    Eric J Kalivoda
    Charles T Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Appl Environ Microbiol 74:3461-70. 2008
  6. ncbi Catabolite repression control of flagellum production by Serratia marcescens
    Nicholas A Stella
    Charles T Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, University of Pittsburgh Eye Center, EEI 1020, 203 Lothrop Street, Pittsburgh, PA 15213, USA
    Res Microbiol 159:562-8. 2008
  7. ncbi Validation of real-time PCR for laboratory diagnosis of Acanthamoeba keratitis
    Paul P Thompson
    The Charles T Campbell Ophthalmic Microbiology Laboratory, Ophthalmology and Visual Sciences Research Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    J Clin Microbiol 46:3232-6. 2008
  8. ncbi CAP37-derived antimicrobial peptides have in vitro antiviral activity against adenovirus and herpes simplex virus type 1
    Y Jerold Gordon
    The Charles T Campbell Lab Ophthalmic Microbiology Laboratory, UPMC Eye Center, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    Curr Eye Res 34:241-9. 2009
  9. ncbi Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models
    Regis P Kowalski
    Department of Ophthalmology Microbiology, The Eye and Ear Institute of Ophthalmology Microbiology, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Acta Ophthalmol 88:e120-5. 2010
  10. ncbi Cyclic AMP negatively regulates prodigiosin production by Serratia marcescens
    Eric J Kalivoda
    Charles T Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, University of Pittsburgh Eye Center, Pittsburgh, PA 15213, USA
    Res Microbiol 161:158-67. 2010

Research Grants

  1. Novel virulence and exoenzyme regulators
    ROBERT M SHANKS; Fiscal Year: 2010

Collaborators

Detail Information

Publications18

  1. ncbi Development of a novel system for isolating genes involved in predator-prey interactions using host independent derivatives of Bdellovibrio bacteriovorus 109J
    Adrian A Medina
    Department of Oral Biology, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07101, USA
    BMC Microbiol 8:33. 2008
    ..Although the life cycle of Bdellovibrio has been extensively investigated, very little is known about the mechanisms involved in predation...
  2. ncbi Global transcriptional response to mammalian temperature provides new insight into Francisella tularensis pathogenesis
    Joseph Horzempa
    Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
    BMC Microbiol 8:172. 2008
    ..After infecting a mammalian host, the facultative intracellular bacterium, Francisella tularensis, encounters an elevated environmental temperature. We hypothesized that this temperature change may regulate genes essential for infection...
  3. ncbi New yeast recombineering tools for bacteria
    Robert M Q Shanks
    Department of Ophthalmology, University of Pittsburgh Eye Center, PA 15213, USA
    Plasmid 62:88-97. 2009
    ..As a demonstration of utility, some of the approaches and vectors generated in this study were used to make a pigP deletion mutation in the opportunistic pathogen Serratia marcescens...
  4. ncbi A Serratia marcescens OxyR homolog mediates surface attachment and biofilm formation
    Robert M Q Shanks
    Charles T Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, UPMC Eye Center, Pittsburgh, PA 15213, USA
    J Bacteriol 189:7262-72. 2007
    ..Together, these data support a model in which OxyR contributes to early stages of S. marcescens biofilm formation by influencing fimbrial gene expression...
  5. ncbi The cyclic AMP-dependent catabolite repression system of Serratia marcescens mediates biofilm formation through regulation of type 1 fimbriae
    Eric J Kalivoda
    Charles T Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Appl Environ Microbiol 74:3461-70. 2008
    ..The regulatory pathway by which environmental carbon sources influence cAMP concentrations to alter production of type 1 fimbrial adhesins establishes a novel mechanism by which bacteria control biofilm development...
  6. ncbi Catabolite repression control of flagellum production by Serratia marcescens
    Nicholas A Stella
    Charles T Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, University of Pittsburgh Eye Center, EEI 1020, 203 Lothrop Street, Pittsburgh, PA 15213, USA
    Res Microbiol 159:562-8. 2008
    ..Given the role of flagella in bacterial pathogenicity, the regulatory pathway described here may assist us in better understanding the putative role of motility in dissemination and virulence of this opportunistic pathogen...
  7. ncbi Validation of real-time PCR for laboratory diagnosis of Acanthamoeba keratitis
    Paul P Thompson
    The Charles T Campbell Ophthalmic Microbiology Laboratory, Ophthalmology and Visual Sciences Research Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    J Clin Microbiol 46:3232-6. 2008
    ..Polyhexamethylene biguanide can inhibit PCR, and we suggest that specimen collection occur prior to topical treatment to avoid possible false-negative results...
  8. ncbi CAP37-derived antimicrobial peptides have in vitro antiviral activity against adenovirus and herpes simplex virus type 1
    Y Jerold Gordon
    The Charles T Campbell Lab Ophthalmic Microbiology Laboratory, UPMC Eye Center, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    Curr Eye Res 34:241-9. 2009
    ..The antiviral activity of an established antibacterial CAP37 domain and its extracellular mechanism of action were investigated...
  9. ncbi Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models
    Regis P Kowalski
    Department of Ophthalmology Microbiology, The Eye and Ear Institute of Ophthalmology Microbiology, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Acta Ophthalmol 88:e120-5. 2010
    ..To determine whether topical levofloxacin 1.5% will successfully treat both levofloxacin-resistant and susceptible Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA) in rabbit keratitis models...
  10. ncbi Cyclic AMP negatively regulates prodigiosin production by Serratia marcescens
    Eric J Kalivoda
    Charles T Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, University of Pittsburgh Eye Center, Pittsburgh, PA 15213, USA
    Res Microbiol 161:158-67. 2010
    ..These experiments establish cAMP as a negative regulator of prodigiosin production in S. marcescens...
  11. ncbi Francisella tularensis DeltapyrF mutants show that replication in nonmacrophages is sufficient for pathogenesis in vivo
    Joseph Horzempa
    Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA
    Infect Immun 78:2607-19. 2010
    ..These findings indicate that replication in nonmacrophages contributes to the pathogenesis of F. tularensis...
  12. ncbi Utilization of an unstable plasmid and the I-SceI endonuclease to generate routine markerless deletion mutants in Francisella tularensis
    Joseph Horzempa
    Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
    J Microbiol Methods 80:106-8. 2010
    ..For counterselection, we adapted a strategy using I-SceI, which causes a double-stranded break in the integrated suicide vector, forcing a second recombination to mediate allelic replacement...
  13. ncbi A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge
    J B Wingard
    UPMC Eye Center, Ophthalmology and Visual Sciences Research Center, Eye and Ear Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15208, USA
    Antimicrob Agents Chemother 55:3788-94. 2011
    ..A range of antibiotic effectiveness was displayed in this cell association assay, providing data that may be considered in addition to traditional testing when determining therapeutic dosing regimens...
  14. ncbi Genetic evidence for an alternative citrate-dependent biofilm formation pathway in Staphylococcus aureus that is dependent on fibronectin binding proteins and the GraRS two-component regulatory system
    Robert M Q Shanks
    Department of Microbiology and Immunology, Dartmouth Medical School, Hanover, NH 03755, USA
    Infect Immun 76:2469-77. 2008
    ..aureus catheter models of infection, we propose that the citrate-stimulated biofilm formation pathway may represent a clinically relevant pathway for the formation of these bacterial communities on medical implants...
  15. ncbi Saccharomyces cerevisiae-based molecular tool kit for manipulation of genes from gram-negative bacteria
    Robert M Q Shanks
    Department of Microbiology and Immunology, Dartmouth Medical School, Hanover, NH 03755, USA
    Appl Environ Microbiol 72:5027-36. 2006
    ..These tools can be used for genetic studies of pseudomonads and many other gram-negative bacteria...
  16. ncbi Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces
    Robert M Q Shanks
    Department of Microbiology and Immunology, Dartmouth Medical School, Hanover, NH 03755, USA
    Nephrol Dial Transplant 21:2247-55. 2006
    ..A novel and potential clinically relevant finding of the present study is the observation that citrate at low levels strongly stimulates biofilm formation by S. aureus...
  17. ncbi Rhamnolipids modulate swarming motility patterns of Pseudomonas aeruginosa
    Nicky C Caiazza
    Department of Microbiology and Immunology, Rm. 505, Vail Building, Dartmouth Medical School, Hanover, NH 03755, USA
    J Bacteriol 187:7351-61. 2005
    ..The abilities to produce and respond to rhamnolipids in the context of group behavior are discussed...
  18. ncbi Heparin stimulates Staphylococcus aureus biofilm formation
    Robert M Q Shanks
    Department of Microbiology and Immunology, Dartmouth Medical School, Hanover, New Hampshire 03755, USA
    Infect Immun 73:4596-606. 2005
    ..These finding suggests that heparin stimulates S. aureus biofilm formation via a novel pathway...

Research Grants1

  1. Novel virulence and exoenzyme regulators
    ROBERT M SHANKS; Fiscal Year: 2010
    ..The answers to these questions will allow for the creation of new drugs to treat S. marcescens ocular infections and reduce infection-associated vision loss. ..